A phase II randomized study of cisplatin (CDDP), raltitrexed (TOM), levofolinic acid (LFA), and 5-fluorouracil (5-FU), or CDDP, methotrexate (MTX), LFA and 5-FU in locally advanced (LAD) or metastatic (M) head and neck cancer (HNC)

✍ Scribed by F. Caponigro; P. De Rosa; G. Rosati; A. Avallone; L. De Lucia; B. Morrica; F. Ionna; G.S. Bruni; P. Comella; G. Comella

• Book ID: 117658243
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 364 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(01)80874-1